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Abstract 
 
MS is the disease of the central nervous system 
in which myelin sheath of the optic nerves is 
degraded. According to the role of estrogen in 
the embryonic distinctions and that the estrogen 
is a female sex hormone and considering the high 
prevalence of MS in women and in regard of the 
fact that the sex hormones carry out their effects 
using their own specific receptors, the present 
study aims at determining the role of estrogen 
receptor gene in patients with MS in Azerbaijan-
e-Gharbi Province and comparing the gen in 
both the patients and the healthy individuals so 
as to make it clear what role do estrogen and its 
receptor genes play in MS disease. 
 
The present study is a case-control study that 
was conducted on MS patients who had referred 
to Orumia’s Imam Khomeini (may Allah 
consecrate the soil of his tomb) Hospital. The 
study sample volume was consisted of two 
groups: one group comprised of 30 women with 
MS and another group composed of 30 healthy 
women who had been randomly assigned to 
these groups. Blood samples, 2cc, were taken 
from all the patients following which the DNAs 
of the patients were extracted and the estrogen 
hormone receptor gene, named ESR1, was 
subjected to examination based on RFLP 
method. Next, the information was analyzed 
using SPSS software, version 21. 
 
In patients with MS, eight cases (26.7%) had 
homozygous gene, five cases (16.6%) had 
heterozygous gene and 17 cases (56.7%) had 
  Resumen  
 
La EM es la enfermedad del sistema nervioso 
central en la cual la vaina de mielina de los 
nervios ópticos se degrada. De acuerdo con el 
papel del estrógeno en las distinciones 
embrionarias, el hecho de que estrógeno es una 
hormona sexual femenina, en consideración de 
la alta prevalencia de EM en las mujeres y en 
relación con el hecho de que las hormonas 
sexuales llevan a cabo sus efectos utilizando sus 
propios receptores específicos, el objetivo del 
estudio es determinar el papel del gen del 
receptor de estrógeno en pacientes con EM en 
la provincia de Azerbaiyán-e-Gharbi y comparar 
el gen tanto en los pacientes como en los 
individuos sanos para aclarar qué papel 
desempeñan los genes del estrógeno y sus 
receptores en la EM. enfermedad. 
 
El presente estudio es un estudio de casos y 
controles que se realizó en pacientes con EM 
que se habían referido al hospital Imam 
Khomeini de Orumia (que Allah consagra el 
suelo de su tumba). El volumen de la muestra 
del estudio consistió en dos grupos: un grupo 
compuesto por 30 mujeres con EM y otro grupo 
compuesto por 30 mujeres sanas que habían 
sido asignadas al azar a estos grupos. Se tomaron 
muestras de sangre, 2cc, de todos los pacientes, 
después de lo cual se extrajeron los ADN de los 
pacientes y el gen receptor de la hormona 
estrógeno, llamado ESR1, se sometió a un 
examen basado en el método RFLP. A 
continuación, la información se analizó 
utilizando el software SPSS, versión 21. 
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healthy gene; in the healthy individuals of the 
control group, zero cases had homozygous gene, 
3 cases (10%) had heterozygous gene and 27 
cases (90%) had healthy genes. 
 
The genotypic and allelic frequencies of Era 
rs2234693 (C/T) polymorphism shows a 
significant difference between the patient and 
control groups. 
 
Keywords: multiple sclerosis, estrogen 
receptor, polymorphism, PCR-RFLP 
 
 
 
En los pacientes con EM, ocho casos (26.7%) 
tenían un gen homocigoto, cinco casos (16.6%) 
tenían un gen heterocigoto y 17 casos (56.7%) 
tenían un gen sano; en los individuos sanos del 
grupo control, cero casos tenían un gen 
homocigoto, 3 casos (10%) tenían un gen 
heterocigoto y 27 casos (90%) tenían genes 
sanos. 
 
Las frecuencias genotípicas y alélicas del 
polimorfismo Era rs2234693 (C / T) muestran 
una diferencia significativa entre los grupos de 
pacientes y de control. 
 
Palabras clave: esclerosis múltiple, receptor 
de estrógeno, polimorfismo, PCR-RFLP 
 
Resumo
 
A EM é a enfermaria do sistema nervoso central na doença da vuelva de mielina dos nervos ópticos se 
degrada. De acordo com o papel do estrogênio em distúrbios embrionários, o hecho de que o estrógeno 
é uma hormona sexual feminina, uma consideração de alta prevalência de EM e as mulheres e a relação 
com o hecho de que as hormonas sexuais são um cabo de seus efeitos Utilizando os receptores específicos, 
o estudo do estado do papel do gene do receptor de estrógeno em pacientes com EM é a província do 
Azerbaijão-e-Gharbi e comparando o genérico dos pacientes com os sintomas específicos para o papel 
desempeñan los genes del estrógeno y sus receptores en la EM. enfermedad. 
 
The present estudio of cases in control control and patients in the development of hospital Imam 
Khomeini de Orumia (que Allah consagram o suelo de su tumba). O volume da música do estúdio consistiu 
em dois grupos: um grupo composto por 30 mulheres e o grupo composto por 30 mulheres que tinham 
sido submetidas a todos os grupos. Se tomaron a sangre de sangre, 2cc, de todos os pacientes, despiste-
se do extra para o ADN dos pacientes e o receptor genérico do estrogênio, chama-se ESR1, é considerado 
um exame baseado no RFLP do método. A continuação, a informação é utilizada com o software SPSS, 
versão 21. 
 
En los pacientes with EM, that document cases (26.7%) tening un homocigoto, minus casos (16.6%) dez 
heterocigoto e 17 casos (56.7%) tenían un gen sano; en los individuos sanos del grupo control, cero cases 
tenían un gen homocigoto, 3contents (10%) tenun un gen heterocigoto y 27cursos (90%) tenían genes 
sanos. 
 
As frecuencias genotípicas e alélicas do polimorfismo Era rs2234693 (C / T) muestrana importante entre 
os grupos de pacientes e controle. 
 
Palavras-chave: esclerose múltipla, receptor de estrogênio, polimorfismo, PCR-RFLP 
 
Introduction 
 
MS is a chronic CNS disease that has influenced 
more than two million individuals worldwide 
(Hauser, 1994) and it occurs more frequently in 
women than in men and it is considered as one 
of the most common reasons giving rise to 
abnormal nervous disability in adults. Although 
there is not a clear-cut reason identified for the 
occurrence of MS, a multifactorial model, 
incorporating the interactions between the 
genetic infections, epigenetic infections, 
nutritional factors, climatic factors as well as an 
array of the other environmental factors, 
including infections with Barr Virus, has been 
designed to make predictions in this regard 
(Hedström, Alfredsson & Olsson, 2016; Olsson, 
Barcellos & Alfredsson, 2017; Rhead et al., 2016). 
In MS, the myelin sheath is firstly degraded and 
then the cells producing the sheath, i.e. 
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oligodendrocytes, are damaged (Richardson, 
1994). MS usually affects the adults or young 
adults ranging in age from 20 to 40 years and it 
has been recognized as the most substantial 
disease disabling the individuals below 65 years 
of age (Sundqvist et al., 2014). It is believed that 
the sex hormones exert a considerable effect on 
the inflictions with MS. Although the mechanism 
by which the hormones influence autoimmunity 
is yet to be clarified, it seems that the female 
hormones are effective on the antigenic 
processes and antigen secretion as a result of 
which the immunity responses are intensified and 
corroborated (Tanriverdi et al., 2003). The 
studies performed by Tanriverdi et al indicated 
that estrogen exerts a remarkable effect on the 
leukocytes in such a way that they stimulate the 
immune system while androgens play a curbing 
role. So, it can be stated that androgens play a 
protective MS counteracting role, whereas the 
estrogens set the ground for their growth and 
this can justify their more prevalence in the 
female gender (Tanriverdi et al., 2003). Estrogen 
is one of the two steroid female sex hormones 
secreted by the ovary. The majority of the 
pituitary regulations of the ovary take place 
through the effect of two hormones, named 
estrogen and progesterone. Estrogen plays a 
significant role in the embryonic development, 
the expression of secondary sex traits, fertility 
cycles and gestation maintenance. Moreover, 
estrogen regulates the growth and distinction of 
endometrium cells (Meldrum, 1993). Also, 
estrogen is influential in the pathological 
processes of diseases associated with hormones 
like ovary cancer, breast cancer, intestine cancer 
and bone cancer (Santen et al., 2008). Estrogen 
receptors (ER) are a collection of transcription 
factors activated through attaching to the ligand 
and they are considered as members of nuclear 
receptor (NR) families (Kumar & Thompson, 
1999; Klings, 2000). Two main groups of 
estrogen receptors are Era and ERB (Koehler et 
al., 2005; Herynk & Fuqua, 2004). Era resides on 
chromosome 6 on 6q25.1 site. The gene is 
comprised of eight axons and 40 kilobases 
(Kuiper et al., 1996; Kuiper & Gustafsson, 1997). 
The present study aims at determining ESR1 
polymorphism in patients with multiple sclerosis 
(MS) and comparing the frequency of ESR1 gene 
polymorphism in patient and control groups. 
 
Materials and Methods 
 
The present study is a case-control research 
that was conducted on the MS patients who had 
referred to Orumia’s Imam Khomeini (may Allah 
consecrate the soil of his tomb) Hospital. The 
study sample volume was consisted of 30 female 
patients with multiple sclerosis and 30 healthy 
female patients. Blood samples, 2cc each, were 
taken from all the patients; next, knowing the 
possibility of storing them for three days in 
refrigerator and then freezer, they were 
transferred to genetic laboratory of Imam 
Khomeini (may Allah consecrate the soil of his 
tomb) Hospital in Ardabil City. In Ardabil’s Imam 
Khomeini (may Allah consecrate the soil of his 
tomb) Hospital, the samples were subjected to 
DNA extraction following which the estrogen 
receptor gene, named ESR1, was examined using 
RFLP method. Afterwards, the effect of the 
genotype (homozygous or heterozygous) on the 
emergence of the disease and the expression of 
the clinical symptoms of the disease were 
investigated following which the information was 
inserted in SPSS software, version 21, to undergo 
further statistical analyses.  
 
Results 
 
The present study takes advantage of Fisher’s 
exact test to investigate the relationship between 
ESR1 genotype and the MS occurrence. The 
study examined 30 patients with MS and 30 
healthy individuals.  
Spectrophotometry was the method of choice 
for quantitative study of the extracted DNA so 
that the DNA concentrations can be ascertained. 
Then, DNA values were calculated in 260 nm 
and 280 nm using OD measurements. Then the 
average DNA absorption rate was read from the 
spectrophotometer for the extracted nucleic 
acid specimens (table 1). 
 
Table 1: quantitative investigation of DNA 
The results of quantitative examination of DNA 
DNA concentration 234 ng/ml 
The 260nm to 280nm ratio 1.78 
The 260nm to 280nm ratio 1.51 
Absorption on 260 nm wavelength 0.154 
Absorption in 280nm wavelength 0.123 
Absorption in 230 nm wavelength 0.134 
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The absorption rate in 260nm/280nm wavelength was over 1.5 that is indicative of the idea that the DNA 
specimen is almost free of any protein and the 260nm/230nm absorption was also found above unity in 
which case the amount of carbohydrate in the DNA specimen is very low, nearly zero (table 1). In order 
to perform a qualitative verification of the condensed DNA, the specimen was subjected to electrophoresis 
on agarose gel. After the electrophoresis of the specimens on 1% agarose gel, the entire samples were 
showing single strips and the results were reflective of a very good quality of the extracted DNA. 
 
To investigate the polymorphism, a pair of primer was designed (table 2) and incision by restriction 
enzymes was conducted after performing PCR, RFLP (table 3). 
 
Table 2: the sequence of the primer pair used in the present study 
 
Gene’s 
name 
Polymorphism Primer sequence 
PCR 
product 
(bp) 
Restriction 
enzyme 
RFLP 
product 
ESR1 rs2234693(T/C) 
F: AGG GTT ATG TGG CAA TGA CG 
R: GTT GCA GCA AAA GGT GTT GC 
 
350bp Pvull 254+96 
 
Table 3: the site of the incision by the enzymes used in the present study 
 
Incision site Restriction enzymes 
CAG CTG Pvull 
 
After the selection of the primers, the PCR protocol was optimized for each pair of the primers, meaning 
that the number of cycles, Ta time and proper MgC12 amount were determined in every PCR protocol 
for every primer pair (table 4). 
 
Table 4: optimized PCR protocol for each primer pair 
  
PCR stages of primer Number of 
cycles 
Temperature 
(°C) and time 
(s) of 
preliminary 
denaturation  
Temperature 
(°C) and time 
(s) of 
denaturation  
Temperature 
(°C) and time 
(s) of 
connection 
Temperature 
(°C) and time 
(s) of 
elongation 
Temperature 
(°C) and time 
(s) of final 
elongation 
MgC12 
amount for 
every 
Mastermix 
(1ml) 
rs2234693(C/T) 35 
95°C 
15 min 
94°C 
1 min 
58°C 
1 min 
72°C 
1 min 
72°C 
10 min 
2.0 
mM 
 
PCR was conducted after the optimization of PCR protocol of each pair of primer for 30 case-patients 
and 30 control subjects. To verify the accuracy of PCR, electrophoresis was carried out on PCR products 
in 1.5% agarose gel stained using safe stain method following which the agarose gel was observed under 
UV. After it was made sure that the PCR protocol has been undertaken properly, RFLP was conducted on 
PCR products to investigate the genotype of every individual for polymorphism. To perform RFLP, Pvull 
restriction enzyme and its suitable buffer and an appropriate amount of PCR product were utilized. To 
examine the RFLP result, electrophoresis was conducted on agarose gel. In patients with MS, eight 
specimens (with a frequency of 26.7%) had homozygous genes, five specimens (with a frequency of 16.6%) 
had heterozygous genes and 17 specimens (with a frequency of 56.7%) were found healthy. In the healthy 
individuals’ group, no specimen was found having homozygous genes, three specimens (with a frequency 
of 10%) had heterozygous genes and 27 specimens (with a frequency of 90%) were healthy (table 5). 
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Table 5: the results of Fisher’s exact test for the investigation of the relationship between ESR1 
polymorphism and MS disease 
 
Group Frequency/percent Homozygote Heterozygote  Healthy Total sum 
MS patients 
frequency 8 5 17 30 
Percentage 26.7% 16.6% 56.7% 100% 
Healthy 
subjects 
frequency 0 3 27 30 
Percentage 0 10% 90% 100% 
Statistic-value 11.311 
P-value 0.002 
Test result The existence of relationship  
 
According to the fact that the amount of P-value obtained for Fisher’s exact test is equal to 0.002 and 
smaller than 0.05, it can be concluded that the relationship between ESR1 gene and MS is confirmed in a 
95% confidence level (F=11.311, P-value<0.05). Based on the frequency values obtained, it is made clear 
that the presence of the homozygous gene has a great influence on an individual’s being diagnosed with MS 
(table 5). 
 
Discussions 
 
Multiple sclerosis is a likely autoimmune 
disease that influences the central nervous 
system (CNS) and it is more prevalent in women 
in comparison to men and it is usually seen 
influencing the individuals in an age range from 
20 to 40 years (van Munster & Uitdehaag, 2017). 
Besides accounting for the MS immunity aspects 
as well as some other cerebral disorders and 
damages, sex hormones regulate the intrinsic 
brain cells like estrogen receptors (Khalaj et al., 
2013). Sex hormones have a great deal of effect 
on the inflictions with MS. Although the 
autoimmunity mechanisms are not well-
identified in MS, the female hormones seem to 
be effective on the antigenic processes and 
hormone secretions as a result of which the 
immunity responses are intensified and 
strengthened (Tanriverdi et al., 2003).  
 
According to what was mentioned up to the 
current point, the present study aims at the 
investigation of the possible effects of estrogen 
hormone receptor gene (ESR) polymorphism on 
multiple sclerosis. It appears that the individual 
differences in the rate of estrogen receptors’ 
expression, or at least part of them, are pertinent 
to the allelic polymorphism inside the regulatory 
regions of the estrogen receptor gene (Pineda et 
al., 2010; Abbasi, Nouri & Azimi, 2012). In a 
study that was carried out by Kikuchi et al on 79 
MS patients and 73 healthy individuals and Pvu11 
and ESR polymorphism in Xba1 was investigated 
based on PCR-RFLP on DNA, the results 
indicated that Pvu11 polymorphism is possibly 
associated with MS development and Xba1 
polymorphism is correlated with the MS 
development age (Kikuchi et al., 2002). In 
another study that was performed by Richard on 
rats with autoimmune encephalomyelitis based 
on an experimental method, it was 
demonstrated that the absence of ESR1 and 
ESR2 restricts the production of inflammatory 
IFN and TFN Gama and Alpha cytokines and the 
reduction of these inflammatory cytokines 
causes decrease in the diseases stemming from 
immune system in the brain and spinal cord 
system, including MS; furthermore, the study 
results showed that immune system can be 
regulated through ESR1’s use of 17-Beta 
Estradiol (Jones et al., 2008). In another study by 
Karine Lelu that was conducted on rats, it was 
indicated that ESR1 expressed in ordinary T-
lymphocytes is the primary intermediary of E2 
(17-Beta Estradiol)’s anti-inflammatory action 
through its being capable of controlling Th1 and 
Th17 cells in secondary lymphocytic tissues (Lelu 
et al., 2011). It was declared in the study by 
Sundermann et al that there are strong evidences 
indicating the relationship between the genetic 
diversity of ESR1 gene and the cognitive outputs. 
The relationship between ESR1 and nervous 
diseases, like cognitive disorder, has been 
ascertained in women and it has been known to 
be a major risk for the diseases leading to the loss 
of reason or dementia. The case-control studies 
demonstrate that X and P alleles of Pvu11 and 
Xba1 polymorphism are prone to risk of MS 
development (Sundermann, Maki & Bishop, 
2010). In a study that was conducted by 
Christianson et al, it was indicated that low 
estrogen states, as in menopausal and post-
delivery period, cause an increase in the intensity 
of the disease in the patients with multiple 
sclerosis. Christianson et al reported that 
estrogen plays a positive role in reducing the 
symptoms and pathological changes of MS 
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(Christianson, Mensah & Shen, 2015). In another 
study by Jessa Haldane, there are numerous 
proofs confirming the estrogen’s treatment 
potentials in autoimmune diseases.  
 
The mechanisms of action include immune 
system and nervous paths and this is reflective of 
the idea that estrogen can usefully influence 
inflammation and nervous diseases (Haldane, 
2012). While the clinical evidences are suggestive 
of the advantages of using estrogen for 
preventing the exacerbation of the disease in 
women with MS, it is well-proved that estrogen 
causes an increase in the central nerves’ effect on 
the central nervous system (CNS). Thus, every 
aspect should be taken into account in using 
estrogen for treating MS (Christianson, Mensah 
& Shen, 2015). 
 
In the current research paper, the existence of 
homozygous mutation was evidenced in eight 
patients and in none of the healthy individuals. All 
of the study subjects, both patients and the 
healthy individuals, had PCR products in 350 nm 
band but, in regard of PCR-RFLP product, eight 
patients showed homozygous mutation in TC 
region that was observed in 254+96nm bands. 
Five patients showed heterozygous mutation and 
three of the healthy subjects were also identified 
with heterozygous mutation. Using the 
calculations made herein, it can be asserted in a 
95% confidence level that 26.7% of the patients 
had homozygous mutation in TC region but no 
trace of such a mutation was documented in the 
healthy subjects. Based on the results, it can be 
stated in a 95% confidence level that there is a 
relationship between gene polymorphism and 
MS. Of course, it is worth mentioning that there 
is a need for further research on the healthy and 
patient individuals from various populations and 
with different genders so that more accurate 
results could be attained. Also, the gene 
expression’s effect on the damaged tissues 
should also be taken into consideration in future 
researches.  
 
Conclusion 
 
The genotypic and allelic frequencies of Era 
rs2234693(C/T) polymorphism causes a 
significant difference amongst the patient and 
control groups. 
 
Suggestions 
 
To obtain more precise results, there is a need 
for performing studies on a larger number of 
healthy and patient individuals from various 
populations with different genders and also the 
gene expression’s effect on the damaged tissues 
is deemed necessary.  
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